Peroxisome proliferator activated receptor gamma agonists suppress TNF alpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species

Abstract

In this study, we investigated the anti-inflammatory effect of various peroxisome proliferator activated receptor gamma (PPAR gamma) agonists (15-deoxy-Delta 12,14-prostaglandin J(2), troglitazone, rosiglitazone, ciglitazone) on human aortic endothelial cells. Pretreatment with PPAR gamma agonists abrogated tumor necrosis factor alpha (TNF alpha)-induced expression of intercellular adhesion molecule-1 (ICAM-1) and subsequent monocytic adhesion by endothelial cells. Because reactive oxygen species (ROS) have been reported to play important roles in pro-inflammatory signal transduction, the involvement of ROS was investigated as a potential mechanism of anti-inflammatory effect of PPAR gamma ligands. Consistent with previous reports in other cell types, blockade of TNF alpha-induced ROS by treatment with N-acetylcysteine, diphertylene iodonium or NADPH oxidase 4 (NOX4) siRNA suppressed TNF alpha-induced ICAM-1 expression and subsequent monocytic adhesion, indicating that TNF alpha mediates pro-inflammatory signals via NOX4-dependent ROS generation in human endothelial cells. Finally, pretreatment with PPAR gamma agonists significantly suppressed TNF alpha-induced increases of intracellular ROS. Our results collectively suggest that PPAR gamma agonists might exert an anti-inflammatory effect on endothelial cells in a ROS-dependent manner. (C) 2007 Elsevier B.V. All rights reserved.